Loading…

Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress

Free radicals are involved in the protective mechanism of preconditioning (PC), whereas antioxidant compounds abolish this benefit. Melatonin is a hormone with antioxidant properties. The aim of our study was to evaluate the effect of melatonin on infarct size in ischemic preconditioning in vivo. We...

Full description

Saved in:
Bibliographic Details
Published in:Free radical biology & medicine 2004-08, Vol.37 (4), p.500-510
Main Authors: Andreadou, Ioanna, Iliodromitis, Efstathios K, Mikros, Emmanuel, Bofilis, Elias, Zoga, Anastasia, Constantinou, Maria, Tsantili-Kakoulidou, Anna, Kremastinos, Dimitrios T
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c379t-14d39e1da10706410e898c382b083facc8e60f0b1bd52f5be17cd5702ac9bbca3
cites cdi_FETCH-LOGICAL-c379t-14d39e1da10706410e898c382b083facc8e60f0b1bd52f5be17cd5702ac9bbca3
container_end_page 510
container_issue 4
container_start_page 500
container_title Free radical biology & medicine
container_volume 37
creator Andreadou, Ioanna
Iliodromitis, Efstathios K
Mikros, Emmanuel
Bofilis, Elias
Zoga, Anastasia
Constantinou, Maria
Tsantili-Kakoulidou, Anna
Kremastinos, Dimitrios T
description Free radicals are involved in the protective mechanism of preconditioning (PC), whereas antioxidant compounds abolish this benefit. Melatonin is a hormone with antioxidant properties. The aim of our study was to evaluate the effect of melatonin on infarct size in ischemic preconditioning in vivo. We randomly divided 33 male rabbits into four groups and subjected them to 30 min of myocardial ischemia and 3 h of reperfusion with the following prior interventions: (i) no intervention, (ii) iv melatonin at a total dose of 50 mg/kg, (iii) PC with two cycles of 5 min ischemia and 10 min reperfusion, and (iv) combined melatonin and PC. In a second series of experiments, another antioxidant agent N-acetylcysteine (NAC) was used in a control and in a PC group. Myocardial infarct size was determined and blood samples were drawn at different time points for the determination of lipid peroxidation products, total superoxide dismutase (SOD) activity, and 1H-NMR spectra to evaluate the changes in the metabolic profile. Melatonin showed no effect on myocardial infarct size in the group of sustained ischemia (42.9 ± 3.6% vs 47.4 ± 4.9%) and it did not attenuate the reduction of myocardial infarct size in the PC group (13.6 ± 2.4% vs 14.0 ± 1.7%). A similar effect was found in NAC-treated groups (44.8 ± 3.4% vs 14.3 ± 1.3%). Lipid peroxidation product levels were significantly elevated in the control and PC groups, whereas melatonin decreased them in both groups. The SOD activity was enhanced in the PC group compared to controls; melatonin kept SOD activity unchanged during ischemia/reperfusion and enhanced its activity when it was combined with PC. Melatonin did not change the metabolic profile of the control and PC groups. Melatonin does not prevent the beneficial effect of ischemic PC on infarct size despite its antioxidant properties.
doi_str_mv 10.1016/j.freeradbiomed.2004.05.005
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66715460</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0891584904003946</els_id><sourcerecordid>66715460</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-14d39e1da10706410e898c382b083facc8e60f0b1bd52f5be17cd5702ac9bbca3</originalsourceid><addsrcrecordid>eNqNkc9u1DAQxi1ERZeWV0CWkLgljJM4ccQJVeWPVMSlPVuOPW5ntWsvsTeCB-C9cdgVEjdOY_n7zYy--Rh7I6AWIPp329rPiLNxE8U9uroB6GqQNYB8xjZCDW3VybF_zjagRlFJ1Y2X7GVKWyigbNULdilkI_umERv26yvuTI6BAncREw8x88OMC4bM8xOWd8xoM8XAo-eU7BPuya6IjcHRKlB45KV9oSVyh-lAGTnlxE0o6g9ypXL0vkzh5tFQSJn_-c60IE95xpSu2YU3u4SvzvWKPXy8vb_5XN19-_Tl5sNdZdthzJXoXDuicEbAAH0nANWobKuaCVTrjbUKe_AwicnJxssJxWCdHKAxdpwma9or9vY0t9j6fsSU9b5Ywt3OBIzHpPt-ELLroYDvT6CdY0ozen2YaW_mn1qAXlPQW_1PCnpNQYPUJYXS_fq85jit2t_e89kLcHsCsJhdCGedLGGw6KgcNmsX6b8W_QYMaaTi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66715460</pqid></control><display><type>article</type><title>Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Andreadou, Ioanna ; Iliodromitis, Efstathios K ; Mikros, Emmanuel ; Bofilis, Elias ; Zoga, Anastasia ; Constantinou, Maria ; Tsantili-Kakoulidou, Anna ; Kremastinos, Dimitrios T</creator><creatorcontrib>Andreadou, Ioanna ; Iliodromitis, Efstathios K ; Mikros, Emmanuel ; Bofilis, Elias ; Zoga, Anastasia ; Constantinou, Maria ; Tsantili-Kakoulidou, Anna ; Kremastinos, Dimitrios T</creatorcontrib><description>Free radicals are involved in the protective mechanism of preconditioning (PC), whereas antioxidant compounds abolish this benefit. Melatonin is a hormone with antioxidant properties. The aim of our study was to evaluate the effect of melatonin on infarct size in ischemic preconditioning in vivo. We randomly divided 33 male rabbits into four groups and subjected them to 30 min of myocardial ischemia and 3 h of reperfusion with the following prior interventions: (i) no intervention, (ii) iv melatonin at a total dose of 50 mg/kg, (iii) PC with two cycles of 5 min ischemia and 10 min reperfusion, and (iv) combined melatonin and PC. In a second series of experiments, another antioxidant agent N-acetylcysteine (NAC) was used in a control and in a PC group. Myocardial infarct size was determined and blood samples were drawn at different time points for the determination of lipid peroxidation products, total superoxide dismutase (SOD) activity, and 1H-NMR spectra to evaluate the changes in the metabolic profile. Melatonin showed no effect on myocardial infarct size in the group of sustained ischemia (42.9 ± 3.6% vs 47.4 ± 4.9%) and it did not attenuate the reduction of myocardial infarct size in the PC group (13.6 ± 2.4% vs 14.0 ± 1.7%). A similar effect was found in NAC-treated groups (44.8 ± 3.4% vs 14.3 ± 1.3%). Lipid peroxidation product levels were significantly elevated in the control and PC groups, whereas melatonin decreased them in both groups. The SOD activity was enhanced in the PC group compared to controls; melatonin kept SOD activity unchanged during ischemia/reperfusion and enhanced its activity when it was combined with PC. Melatonin did not change the metabolic profile of the control and PC groups. Melatonin does not prevent the beneficial effect of ischemic PC on infarct size despite its antioxidant properties.</description><identifier>ISSN: 0891-5849</identifier><identifier>EISSN: 1873-4596</identifier><identifier>DOI: 10.1016/j.freeradbiomed.2004.05.005</identifier><identifier>PMID: 15256221</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acetylcysteine - chemistry ; Acetylcysteine - pharmacology ; Aldehydes - pharmacology ; Animals ; Antioxidant ; Antioxidants - metabolism ; Antioxidants - pharmacology ; Free Radicals ; Infarct size ; Ischemia/reperfusion ; Ischemic Preconditioning ; Lipid Peroxidation ; Magnetic Resonance Spectroscopy ; Male ; Malondialdehyde - pharmacology ; Melatonin ; Melatonin - metabolism ; Metabolic profile ; Models, Statistical ; Oxidative Stress ; Rabbits ; Reperfusion Injury ; Superoxide Dismutase - metabolism ; Time Factors</subject><ispartof>Free radical biology &amp; medicine, 2004-08, Vol.37 (4), p.500-510</ispartof><rights>2004 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379t-14d39e1da10706410e898c382b083facc8e60f0b1bd52f5be17cd5702ac9bbca3</citedby><cites>FETCH-LOGICAL-c379t-14d39e1da10706410e898c382b083facc8e60f0b1bd52f5be17cd5702ac9bbca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15256221$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Andreadou, Ioanna</creatorcontrib><creatorcontrib>Iliodromitis, Efstathios K</creatorcontrib><creatorcontrib>Mikros, Emmanuel</creatorcontrib><creatorcontrib>Bofilis, Elias</creatorcontrib><creatorcontrib>Zoga, Anastasia</creatorcontrib><creatorcontrib>Constantinou, Maria</creatorcontrib><creatorcontrib>Tsantili-Kakoulidou, Anna</creatorcontrib><creatorcontrib>Kremastinos, Dimitrios T</creatorcontrib><title>Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress</title><title>Free radical biology &amp; medicine</title><addtitle>Free Radic Biol Med</addtitle><description>Free radicals are involved in the protective mechanism of preconditioning (PC), whereas antioxidant compounds abolish this benefit. Melatonin is a hormone with antioxidant properties. The aim of our study was to evaluate the effect of melatonin on infarct size in ischemic preconditioning in vivo. We randomly divided 33 male rabbits into four groups and subjected them to 30 min of myocardial ischemia and 3 h of reperfusion with the following prior interventions: (i) no intervention, (ii) iv melatonin at a total dose of 50 mg/kg, (iii) PC with two cycles of 5 min ischemia and 10 min reperfusion, and (iv) combined melatonin and PC. In a second series of experiments, another antioxidant agent N-acetylcysteine (NAC) was used in a control and in a PC group. Myocardial infarct size was determined and blood samples were drawn at different time points for the determination of lipid peroxidation products, total superoxide dismutase (SOD) activity, and 1H-NMR spectra to evaluate the changes in the metabolic profile. Melatonin showed no effect on myocardial infarct size in the group of sustained ischemia (42.9 ± 3.6% vs 47.4 ± 4.9%) and it did not attenuate the reduction of myocardial infarct size in the PC group (13.6 ± 2.4% vs 14.0 ± 1.7%). A similar effect was found in NAC-treated groups (44.8 ± 3.4% vs 14.3 ± 1.3%). Lipid peroxidation product levels were significantly elevated in the control and PC groups, whereas melatonin decreased them in both groups. The SOD activity was enhanced in the PC group compared to controls; melatonin kept SOD activity unchanged during ischemia/reperfusion and enhanced its activity when it was combined with PC. Melatonin did not change the metabolic profile of the control and PC groups. Melatonin does not prevent the beneficial effect of ischemic PC on infarct size despite its antioxidant properties.</description><subject>Acetylcysteine - chemistry</subject><subject>Acetylcysteine - pharmacology</subject><subject>Aldehydes - pharmacology</subject><subject>Animals</subject><subject>Antioxidant</subject><subject>Antioxidants - metabolism</subject><subject>Antioxidants - pharmacology</subject><subject>Free Radicals</subject><subject>Infarct size</subject><subject>Ischemia/reperfusion</subject><subject>Ischemic Preconditioning</subject><subject>Lipid Peroxidation</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Malondialdehyde - pharmacology</subject><subject>Melatonin</subject><subject>Melatonin - metabolism</subject><subject>Metabolic profile</subject><subject>Models, Statistical</subject><subject>Oxidative Stress</subject><subject>Rabbits</subject><subject>Reperfusion Injury</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Time Factors</subject><issn>0891-5849</issn><issn>1873-4596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqNkc9u1DAQxi1ERZeWV0CWkLgljJM4ccQJVeWPVMSlPVuOPW5ntWsvsTeCB-C9cdgVEjdOY_n7zYy--Rh7I6AWIPp329rPiLNxE8U9uroB6GqQNYB8xjZCDW3VybF_zjagRlFJ1Y2X7GVKWyigbNULdilkI_umERv26yvuTI6BAncREw8x88OMC4bM8xOWd8xoM8XAo-eU7BPuya6IjcHRKlB45KV9oSVyh-lAGTnlxE0o6g9ypXL0vkzh5tFQSJn_-c60IE95xpSu2YU3u4SvzvWKPXy8vb_5XN19-_Tl5sNdZdthzJXoXDuicEbAAH0nANWobKuaCVTrjbUKe_AwicnJxssJxWCdHKAxdpwma9or9vY0t9j6fsSU9b5Ywt3OBIzHpPt-ELLroYDvT6CdY0ozen2YaW_mn1qAXlPQW_1PCnpNQYPUJYXS_fq85jit2t_e89kLcHsCsJhdCGedLGGw6KgcNmsX6b8W_QYMaaTi</recordid><startdate>20040815</startdate><enddate>20040815</enddate><creator>Andreadou, Ioanna</creator><creator>Iliodromitis, Efstathios K</creator><creator>Mikros, Emmanuel</creator><creator>Bofilis, Elias</creator><creator>Zoga, Anastasia</creator><creator>Constantinou, Maria</creator><creator>Tsantili-Kakoulidou, Anna</creator><creator>Kremastinos, Dimitrios T</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040815</creationdate><title>Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress</title><author>Andreadou, Ioanna ; Iliodromitis, Efstathios K ; Mikros, Emmanuel ; Bofilis, Elias ; Zoga, Anastasia ; Constantinou, Maria ; Tsantili-Kakoulidou, Anna ; Kremastinos, Dimitrios T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-14d39e1da10706410e898c382b083facc8e60f0b1bd52f5be17cd5702ac9bbca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Acetylcysteine - chemistry</topic><topic>Acetylcysteine - pharmacology</topic><topic>Aldehydes - pharmacology</topic><topic>Animals</topic><topic>Antioxidant</topic><topic>Antioxidants - metabolism</topic><topic>Antioxidants - pharmacology</topic><topic>Free Radicals</topic><topic>Infarct size</topic><topic>Ischemia/reperfusion</topic><topic>Ischemic Preconditioning</topic><topic>Lipid Peroxidation</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Malondialdehyde - pharmacology</topic><topic>Melatonin</topic><topic>Melatonin - metabolism</topic><topic>Metabolic profile</topic><topic>Models, Statistical</topic><topic>Oxidative Stress</topic><topic>Rabbits</topic><topic>Reperfusion Injury</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andreadou, Ioanna</creatorcontrib><creatorcontrib>Iliodromitis, Efstathios K</creatorcontrib><creatorcontrib>Mikros, Emmanuel</creatorcontrib><creatorcontrib>Bofilis, Elias</creatorcontrib><creatorcontrib>Zoga, Anastasia</creatorcontrib><creatorcontrib>Constantinou, Maria</creatorcontrib><creatorcontrib>Tsantili-Kakoulidou, Anna</creatorcontrib><creatorcontrib>Kremastinos, Dimitrios T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Free radical biology &amp; medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andreadou, Ioanna</au><au>Iliodromitis, Efstathios K</au><au>Mikros, Emmanuel</au><au>Bofilis, Elias</au><au>Zoga, Anastasia</au><au>Constantinou, Maria</au><au>Tsantili-Kakoulidou, Anna</au><au>Kremastinos, Dimitrios T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress</atitle><jtitle>Free radical biology &amp; medicine</jtitle><addtitle>Free Radic Biol Med</addtitle><date>2004-08-15</date><risdate>2004</risdate><volume>37</volume><issue>4</issue><spage>500</spage><epage>510</epage><pages>500-510</pages><issn>0891-5849</issn><eissn>1873-4596</eissn><abstract>Free radicals are involved in the protective mechanism of preconditioning (PC), whereas antioxidant compounds abolish this benefit. Melatonin is a hormone with antioxidant properties. The aim of our study was to evaluate the effect of melatonin on infarct size in ischemic preconditioning in vivo. We randomly divided 33 male rabbits into four groups and subjected them to 30 min of myocardial ischemia and 3 h of reperfusion with the following prior interventions: (i) no intervention, (ii) iv melatonin at a total dose of 50 mg/kg, (iii) PC with two cycles of 5 min ischemia and 10 min reperfusion, and (iv) combined melatonin and PC. In a second series of experiments, another antioxidant agent N-acetylcysteine (NAC) was used in a control and in a PC group. Myocardial infarct size was determined and blood samples were drawn at different time points for the determination of lipid peroxidation products, total superoxide dismutase (SOD) activity, and 1H-NMR spectra to evaluate the changes in the metabolic profile. Melatonin showed no effect on myocardial infarct size in the group of sustained ischemia (42.9 ± 3.6% vs 47.4 ± 4.9%) and it did not attenuate the reduction of myocardial infarct size in the PC group (13.6 ± 2.4% vs 14.0 ± 1.7%). A similar effect was found in NAC-treated groups (44.8 ± 3.4% vs 14.3 ± 1.3%). Lipid peroxidation product levels were significantly elevated in the control and PC groups, whereas melatonin decreased them in both groups. The SOD activity was enhanced in the PC group compared to controls; melatonin kept SOD activity unchanged during ischemia/reperfusion and enhanced its activity when it was combined with PC. Melatonin did not change the metabolic profile of the control and PC groups. Melatonin does not prevent the beneficial effect of ischemic PC on infarct size despite its antioxidant properties.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15256221</pmid><doi>10.1016/j.freeradbiomed.2004.05.005</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0891-5849
ispartof Free radical biology & medicine, 2004-08, Vol.37 (4), p.500-510
issn 0891-5849
1873-4596
language eng
recordid cdi_proquest_miscellaneous_66715460
source ScienceDirect Freedom Collection 2022-2024
subjects Acetylcysteine - chemistry
Acetylcysteine - pharmacology
Aldehydes - pharmacology
Animals
Antioxidant
Antioxidants - metabolism
Antioxidants - pharmacology
Free Radicals
Infarct size
Ischemia/reperfusion
Ischemic Preconditioning
Lipid Peroxidation
Magnetic Resonance Spectroscopy
Male
Malondialdehyde - pharmacology
Melatonin
Melatonin - metabolism
Metabolic profile
Models, Statistical
Oxidative Stress
Rabbits
Reperfusion Injury
Superoxide Dismutase - metabolism
Time Factors
title Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T19%3A34%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Melatonin%20does%20not%20prevent%20the%20protection%20of%20ischemic%20preconditioning%20in%20vivo%20despite%20its%20antioxidant%20effect%20against%20oxidative%20stress&rft.jtitle=Free%20radical%20biology%20&%20medicine&rft.au=Andreadou,%20Ioanna&rft.date=2004-08-15&rft.volume=37&rft.issue=4&rft.spage=500&rft.epage=510&rft.pages=500-510&rft.issn=0891-5849&rft.eissn=1873-4596&rft_id=info:doi/10.1016/j.freeradbiomed.2004.05.005&rft_dat=%3Cproquest_cross%3E66715460%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c379t-14d39e1da10706410e898c382b083facc8e60f0b1bd52f5be17cd5702ac9bbca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=66715460&rft_id=info:pmid/15256221&rfr_iscdi=true